When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Langerhans cell histiocytosis

Última revisión: 16 Jul 2025
Última actualización: 04 Mar 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • age <15 years
  • bone pain and/or swelling
  • skin rash
  • polyuria and polydipsia
  • growth or sexual maturation failure
  • vertebra plana
  • hepatosplenomegaly
Todos los datos

Otros factores de diagnóstico

  • cough, dyspnea
  • chest pain
  • orbital abnormalities
  • jaundice
  • ascites
  • cytopenias
  • fever
  • anorexia
  • weight loss
  • irritability
  • ear pain
  • ear discharge
  • hearing loss
  • perforated tympanic membrane
  • headache
  • neurologic signs
  • bloody diarrhea
  • oral mucosa lesions
  • lymphadenopathy
  • thyroid enlargement
Todos los datos

Factores de riesgo

  • smoking
  • family history of thyroid disease
  • perinatal infections
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • CBC
  • LFTs
  • serum albumin
  • renal function
  • serum electrolytes
  • serum calcium
  • inflammatory markers
  • endocrine evaluation (adults)
  • BRAF V600E mutation analysis
  • skeletal survey (children)
  • chest x-ray (children)
  • abdominal ultrasound (children)
  • fluorodeoxyglucose positron emission tomography (FDG-PET) (adults)
  • MRI head with contrast (adults)
  • tissue biopsy
Todos los datos

Pruebas diagnósticas que deben considerarse

  • endocrine evaluation (children)
  • coagulation studies (children)
  • pulmonary function tests
  • echocardiogram
  • high-resolution CT chest
  • audiometry
  • bone marrow aspirate and biopsy
  • MRI head with contrast (children)
  • MRI spine
  • CT head
Todos los datos

Algoritmo de tratamiento

Agudo

single-system disease: bone involvement

single-system disease: skin involvement

single-system disease: isolated lymph node involvement

single-system disease: lung involvement

single-system disease: CNS involvement

single-system disease: neurodegenerative disease

multisystem disease

En curso

relapsed/refractory disease

Colaboradores

Autores

Gaurav Goyal, MD

Assistant Professor of Medicine

University of Alabama at Birmingham

Department of Medicine

Division of Hematology/Oncology

Birmingham

AL

Divulgaciones

GG has been reimbursed for advisory board by Opna Bio LLC, and receives royalties from UpToDate.

Agradecimientos

Dr Gaurav Goyal would like to gratefully acknowledge Dr Oussama Abla and Professor Kimo Stine, previous contributors to this topic.

Divulgaciones

OA declares that he has no competing interests. KS declares that he serves on the Board of the Histiocytosis Association (a nonprofit organization), has provided advice for a legal firm reviewing a case of LCH, and receives honoraria for membership of advisory boards to Pfizer and Behring.

Revisores por pares

R. Maarten Egeler, MD, PhD

Director of Pediatric Immunology, Hematology, Oncology, Bone Marrow Transplantation, and Autoimmune Diseases

Leiden University Medical Center

Leiden

The Netherlands

Divulgaciones

RME has previously worked with Dr Abla on a review of LCH. RME is an author of several references cited in this topic.

Rima Jubran, MD, MPH

Assistant Professor of Pediatrics

Keck School of Medicine

University of Southern California

Children's Hospital Los Angeles

Los Angeles

CA

Divulgaciones

RJ declares that she has no competing interests.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Haupt R, Minkov M, Astigarraga I, et al; Euro Histio Network. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013 Feb;60(2):175-84.Texto completo  Resumen

Goyal G, Tazi A, Go RS, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood. 2022 Apr 28;139(17):2601-21.Texto completo  Resumen

Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood. 2020 Apr 16;135(16):1319-31.Texto completo  Resumen

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: histiocytic neoplasms [internet publication].Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Langerhans cell histiocytosis images
  • Diferenciales

    • Seborrheic dermatitis
    • Juvenile xanthogranuloma (JXG)
    • Rosai-Dorfman disease (RDD)
    Más Diferenciales
  • Guías de práctica clínica

    • Clinical practice guidelines in oncology: histiocytic neoplasms
    • International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
    Más Guías de práctica clínica
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad